LHC Group executives plan a slowed, albeit continued, focus on hospice growth heading into 2022, Hospice News reports.
The company has been bullish on the hospice market in recent years, with hospices deals making up a little more than 60% of in cash flow set aside to further boost its M&A pipeline last quarter. Heading into next year, hospice will be less of a focus for LHC Group, according to CEO Keith Myers. Read more.
